Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Cardlytics, Inc. Common Stock (CDLX)

Services-computer Programming, Data Processing, Etc.

https://www.cardlytics.com

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through three segments, Cardlytics Direct U.S. and U.K., and the Bridg platform. The Cardlytics Direct segment which generates the majority of revenue operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

675 PONCE DE LEON AVENUE, NE, SUITE 6000
ATLANTA, GA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/09/2018

Market Cap

183,924,921

Shares Outstanding

39,250,000

Weighted SO

39,254,146

Total Employees

N/A

Upcoming Earnings

08/06/2024

Similar Tickers

CRTO --.--%

DLX --.--%

EEX --.--%

MCHX --.--%

IAS --.--%

CMPR --.--%

QNST --.--%

IPG --.--%

ADV --.--%

Beta

1.6580

Last Div

0.0000

Range

2.89-20.52

Chg

-0.0597

Avg Vol

1155624

Mkt Cap

183924921

Exch

NASDAQ

Country

US

Phone

888 798 5802

DCF Diff

4.2701

DCF

11.4201

Div Yield

0.0000

P/S

0.6022

EV Multiple

-11.0483

P/FV

0.8619

Div Yield %

0.0000

P/E

-1.1806

PEG

-0.1003

Payout

0.0000

Current Ratio

1.7718

Quick Ratio

1.7718

Cash Ratio

0.6811

DSO

128.3134

DIO

0.0000

Op Cycle

128.3134

DPO

10.5524

CCC

117.7609

Gross Margin

0.4489

Op Margin

-0.2189

Pretax Margin

-0.5021

Net Margin

-0.5021

Eff Tax Rate

-0.7407

ROA

-0.2869

ROE

-0.7973

ROCE

-0.1556

NI/EBT

1.0000

EBT/EBIT

2.2937

EBIT/Rev

-0.2189

Debt Ratio

0.4027

D/E

1.0245

LT Debt/Cap

0.5034

Total Debt/Cap

0.5060

Int Coverage

-18.5234

CF/Debt

-0.0421

Equity Multi

2.5442

Rec Turnover

2.8446

Pay Turnover

34.5892

Inv Turnover

999999.9999

FA Turnover

28.9686

Asset Turnover

0.5715

OCF/Share

-0.1847

FCF/Share

-0.5200

Cash/Share

1.4524

OCF/Sales

-0.0297

FCF/OCF

2.8157

CF Coverage

-0.0421

ST Coverage

-3.9628

CapEx Coverage

-0.5508

Div&CapEx Cov

-0.5508

P/BV

0.8619

P/B

0.8619

P/S

0.6022

P/E

-1.1806

P/FCF

-7.2108

P/OCF

-19.9836

P/CF

-19.9836

PEG

-0.1003

P/S

0.6022

EV Multiple

-11.0483

P/FV

0.8619

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Feb 13, 00:05 Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman GlobeNewswire Inc. Feb 12, 00:04 Cardlytics, Inc. Shareholders with Large Losses Should Contact Robbins LLP for Information About the CDLX Class Action Lawsuit GlobeNewswire Inc. Jan 29, 02:32 Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman GlobeNewswire Inc. Jan 25, 00:00 Cardlytics, Inc. Announcement: If You Have Suffered Losses in Cardlytics, Inc. (NASDAQ: CDLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Aug 27, 01:00 Bragar Eagel & Squire, P.C. Is Investigating Arhaus, Cardlytics, and CVRx and Encourages Investors to Contact the Firm GlobeNewswire Inc. Aug 19, 20:58 Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman GlobeNewswire Inc. Aug 13, 22:34 Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman GlobeNewswire Inc. Dec 19, 07:30 Cardlytics Announces Multi-Year Contract Renewal with Lloyds Bank Plc GlobeNewswire Inc. Oct 27, 17:09 Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Oct 26, 08:30 Cardlytics Announces Timing of Its Third Quarter 2023 Financial Results Conference Call and Webcast

Revenue Product Segmentation